Centiva Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$423K Buy
1,093
+293
+37% +$109K ﹤0.01% 1000
2026
Q1
$234K Buy
800
+29
+4% +$9.53K ﹤0.01% 1195
2025
Q4
$270K Buy
+771
New +$261K ﹤0.01% 887
2025
Q1
Sell
-2,560
Closed -$944K 1698
2024
Q4
$944K Sell
2,560
-4,901
-66% -$2.05M 0.02% 543
2024
Q3
$3.88M Buy
7,461
+4,089
+121% +$2.18M 0.08% 217
2024
Q2
$1.83M Buy
+3,372
New +$1.78M 0.03% 471
2024
Q1
Sell
-852
Closed -$402K 1889
2023
Q4
$402K Sell
852
-1,098
-56% -$508K 0.01% 1063
2023
Q3
$849K Sell
1,950
-2,485
-56% -$1.13M 0.02% 715
2023
Q2
$1.97M Buy
+4,435
New +$2.05M 0.04% 391
2022
Q4
Sell
-2,407
Closed -$1.09M 1424
2022
Q3
$1.09M Sell
2,407
-138
-5% -$66K 0.02% 581
2022
Q2
$1.23M Buy
2,545
+2,273
+836% +$1.12M 0.03% 520
2022
Q1
$134K Buy
+272
New +$124K ﹤0.01% 1353
2021
Q4
Sell
-338
Closed -$142K 1291
2021
Q3
$126K Buy
+338
New +$128K 0.01% 1003
2021
Q2
Sell
-1,013
Closed -$364K 1439
2021
Q1
$364K Buy
+1,013
New +$326K 0.01% 684
2020
Q3
Sell
-1,497
Closed -$394K 740
2020
Q2
$394K Sell
1,497
-3,192
-68% -$852K 0.02% 346
2020
Q1
$1.06M Buy
4,689
+2,173
+86% +$592K 0.05% 190
2019
Q4
$760K Buy
+2,516
New +$692K 0.04% 332

Other funds holding ELV

Centiva Capital's ELV Position: Q2 2026 in Review

Centiva Capital increased its Elevance Health (ELV) stake by 37% in Q2 2026, buying an estimated $109K and bringing the position to 1,093 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #1000.

Centiva Capital first reported a position in ELV in Q4 2019 and has held it in 17 quarters since. The position peaked at $3.88M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Centiva Capital held 1,093 shares of Elevance Health worth $423K as of Q2 2026.
  • Centiva Capital bought 293 Elevance Health shares in Q2 2026, an estimated $109K.
  • Elevance Health made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1000 holding.
  • Centiva Capital first reported a position in Elevance Health in Q4 2019 and has held it in 17 quarters since.
  • Centiva Capital's Elevance Health position peaked at $3.88M in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.